Bagnasco Francesca, Piaggio Giorgio, Mesini Alessio, Mariani Marcello, Russo Chiara, Saffioti Carolina, Losurdo Giuseppe, Palmero Candida, Castagnola Elio
Scientific Directorate, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Antibiotics (Basel). 2022 May 26;11(6):720. doi: 10.3390/antibiotics11060720.
Antibiotic resistance is an increasing problem, especially in children with urinary tract infections. Rates of drug-specific resistant pathogens were reported, and an easy prediction model to guide the clinical decision-making process for antibiotic treatment was proposed. Data on microbiological isolation from urinoculture, between January 2007−December 2018 at Istituto Gaslini, Italy, in patients aged <19 years were extracted. Logistic regression-based prediction scores were calculated. Discrimination was determined by the area under the receiver operating characteristic curve; calibration was assessed by the Hosmer and Lemeshow test and the Spiegelhalterz test. A total of 9449 bacterial strains were isolated in 6207 patients; 27.2% were <6 months old at the first episode. Enterobacteriales (Escherichia coli and other Enterobacteriales) accounted for 80.4% of all isolates. Amoxicillin-clavulanate (AMC) and cefixime (CFI) Enterobacteriales resistance was 32.8% and 13.7%, respectively, and remained quite stable among the different age groups. On the contrary, resistance to ciprofloxacin (CIP) (overall 9.6%) and cotrimoxazole (SXT) (overall 28%) increased with age. After multivariable analysis, resistance to AMC/CFI could be predicted by the following: sex; age at sampling; department of admission; previous number of bacterial pathogens isolated. Resistance to CIP/SXT could be predicted by the same factors, excluding sex. The models achieved very good calibration but moderate discrimination performance. Specific antibiotic resistance among Enterobacteriales could be predicted using the proposed scoring system to guide empirical antibiotic choice. Further studies are needed to validate this tool.
抗生素耐药性问题日益严重,尤其是在患有尿路感染的儿童中。报告了特定药物耐药病原体的发生率,并提出了一种简单的预测模型,以指导抗生素治疗的临床决策过程。提取了2007年1月至2018年12月期间在意大利加斯利尼研究所<19岁患者尿培养的微生物分离数据。计算了基于逻辑回归的预测分数。通过受试者工作特征曲线下的面积来确定区分度;通过Hosmer和Lemeshow检验以及Spiegelhalterz检验来评估校准情况。在6207例患者中共分离出9449株细菌菌株;首次发病时27.2%的患者年龄<6个月。肠杆菌科(大肠杆菌和其他肠杆菌科)占所有分离株的80.4%。阿莫西林-克拉维酸(AMC)和头孢克肟(CFI)对肠杆菌科的耐药率分别为32.8%和13.7%,在不同年龄组中保持相当稳定。相反,对环丙沙星(CIP)(总体9.6%)和复方新诺明(SXT)(总体28%)的耐药率随年龄增加。多变量分析后,对AMC/CFI的耐药性可通过以下因素预测:性别;采样时的年龄;入院科室;既往分离出的细菌病原体数量。对CIP/SXT的耐药性可通过相同因素预测,但不包括性别。这些模型具有非常好的校准,但区分性能中等。使用所提出的评分系统可以预测肠杆菌科中的特定抗生素耐药性,以指导经验性抗生素选择。需要进一步研究来验证该工具。